About the cover
August 2008 Volume 26 No 8
An artist's impression of targeted delivery of cytotoxic drugs to a cancer cell by internalization of the complex formed between antibody-drug conjugate (ADC) and its antigen. Junutula et al. produce near-homogenous ADCs that are better tolerated than conventional ADCs without any loss of anti-tumor activity (p 925). Credit: Allison Bruce, Genentech, Inc.
